ライフサイエンスコーパス: nerve graft

1 ICN was performed using a sural nerve graft.

2 reatment is surgery, requiring an autologous nerve graft.

3 ction, regardless of the BDNF content of the nerve graft.

4 ding to the development of the bioartificial nerve graft.

5 nd the great auricular nerve (GAN) as a free nerve graft.

6 o the permissive environment of a peripheral nerve graft.

7 to the clinical standard of care, autologous nerve grafts.

8 rve conduits as an alternative to autologous nerve grafts.

9 -promoting properties of freeze-killed donor nerve grafts.

10 can extend for long distances in peripheral nerve grafts.

11 reported poor permeability of freeze-thawed nerve grafts.

12 ficantly reduced in the 12-month degenerated nerve grafts.

13 nerative potential of normal and degenerated nerve grafts.

14 /-) axons robustly grew into mouse wild-type nerve grafts.

15 ned with their low immunogenicity, acellular nerve grafts activated by in vitro predegeneration may b

16 The effect of motor versus sensory nerve grafting after facial nerve injury has not been pr

17 d to grow across a predegenerated peripheral nerve graft and back into the thoracic spinal cord.

18 nsity of ascending axons growing through the nerve graft and scar tissue present at the rostral spina

19 unctional recovery depends on the age of the nerve graft, and not the age of the host.

20 long, nonhealing nerve gaps, the autologous nerve graft (autograft), has several drawbacks.

21 r grafts and, compared with normal acellular nerve grafts, axonal ingress in vivo was approximately d

22 essentially no fibers had extended from the nerve graft back into the spinal cord.

23 Enthusiasm has declined for sural nerve grafting because of the associated complexity of t

24 ve spinal cord injury, we built a peripheral nerve graft bridge (PNG) through the cystic cavity and t

25 XTas near the rostral border of a peripheral nerve graft bridging the transected dorsal columns in th

26 process and whether effective predegenerated nerve grafts could be produced in vitro.

27 of axial cryosections of human cross-facial nerve grafts demonstrated enhanced resolution of small-c

28 nerve extracellular matrix is the extracted nerve graft (eNG).

29 into the dorsal column, 3 mm rostral to the nerve graft, essentially no fibers had extended from the

30 xus allotransplantation could offer the best nerve graft fulfilling the like-with-like principle.

31 However, autologous nerve graft harvesting is not without risks, with associ

32 nd extent of regeneration, the bioartificial nerve graft holds great promise for improving recovery i

33 ation of Purkinje cell axons into peripheral nerve grafts implanted into the cerebellum was examined.

34 nal axon outgrowth into implanted peripheral nerve grafts in a rat model of brachial plexus avulsion,

35 transplanted a growth supporting peripheral nerve graft into the lesion cavity, and enzymatically mo

36 red regeneration through OPN(-/-) peripheral nerves grafted into OPN(+/+) mice indicated that loss of

37 Repair using peripheral nerve grafts is a promising restorative surgical treatme

38 orogold tracing in an optic nerve-peripheral nerve graft model.

39 factor expression between sensory and motor nerve, grafts of cutaneous nerve or ventral root were de

40 Nerve gaps were bridged by either a sural nerve graft or a biodegradable collagen nerve guide tube

41 l cord provided with a permissive peripheral nerve graft (PNG) as well as in crushed optic nerve.

42 ), alone or in conjunction with a peripheral nerve graft (PNG), to alter the molecular program of inj

43 ration out of a growth-supportive peripheral nerve grafted (PNG) into the SCI cavity.

44 regenerate into growth-permissive peripheral nerve grafts (PNGs) reenter host tissue to mediate funct

45 axons into apposed predegenerated peripheral nerve grafts (PNGs).

46 injected into the eNG to form recellularized nerve grafts (rNG).

47 ur studies provide evidence that an enhanced nerve grafting strategy represents a potential regenerat

48 sent study, we modified a classic peripheral nerve grafting technique with the use of chondroitinase

49 We are developing tissue-engineered nerve grafts (TENGs) to simultaneously "bridge" missing

50 onths after nerve sprouting was induced by a nerve graft, the same NMJs were restained and reexamined

51 al anesthesia underwent nerve transfers with nerve grafting to restore corneal sensation.

52 ing nerve gap injuries involve using sensory nerve grafts to bridge the nerve defect.

53 mammals or regenerate axons into peripheral nerve grafts to test the importance of these molecules f

54 d regeneration nerve fibers through CLU(-/-) nerve grafts transplanted into CLU(+/+) mice indicated t

55 ated their axons through a 1.5 cm peripheral nerve graft twofold relative to uninjected controls and

56 e developed a method for preparing cell-free nerve grafts using lysophosphatidylcholine to remove cel

57 When a predegenerated nerve graft was implanted into double-transgenic mice, p

58 cut flush to the spinal cord and a peroneal nerve graft was inserted into the lateral spinal cord at

59 of sensory fibers in the rostral end of the nerve graft was not significantly different between cont

60 Surgeons have typically used autologous nerve grafts, which have several drawbacks including the

61 achieved with minimal morbidity using sural nerve grafts, which surgeons commonly use to reconstruct

62 ected optic nerve after intravitreal sciatic nerve grafting without inhibitory ligand neutralization.